For a company building its business around water electrolysis, Newtrace has made a telling pivot. The Bengaluru-based startup has quietly abandoned its ambitions to manufacture complete hydrogen production systems, choosing instead to focus on something more prosaic—and potentially more profitable.
That shift appears to be paying off, at least in the eyes of investors. On March 10, 2026, Newtrace announced a $6.3 million Pre-Series A round co-led by HDFC Bank Limited and Mitsui Sumitomo Insurance Venture Capital, with its existing backers—Peak XV's Surge, Aavishkaar Capital, Speciale Invest, and Micelio Technology Fund—pitching in alongside angel investors Manish Prataprai Gandhi and Renu Manish Gandhi. The deal pegged the company's post-money valuation at roughly $30 million.
The funding will bankroll pilot-scale manufacturing of what Newtrace calls Voltagen electrodes: proprietary components engineered as drop-in replacements for alkaline water electrolysers. If the company hits its timeline, initial commercial deliveries should reach customers within a year—by March 2027, assuming all goes according to plan.
From Systems to Components
Prasanta Sarkar and Rochan Sinha founded Newtrace in 2021, and for much of its early life, the company's pitch centered on membrane-less electrolyser technology. Industry coverage through 2024 reinforced that narrative. But somewhere along the way, the founders appear to have recalibrated their ambitions. Today, Newtrace isn't building electrolysers. It's selling the electrodes and components that go inside them—to electrolyser manufacturers, project developers, and industrial gas companies.
It's a strategic retreat, perhaps, though the company would likely describe it as focus. Either way, the economics may be more forgiving. Manufacturing electrolysers at scale requires deeper capital, longer sales cycles, and the kind of project risk that scares off all but the most patient investors. Selling components to established players? That's a faster path to revenue, even if the margins are tighter.
Newtrace is now running pilots with two of India's largest state-owned energy companies: Bharat Petroleum Corporation Limited (BPCL) and Oil and Natural Gas Corporation (ONGC). Company materials cite the BPCL pilot as achieving 99.9% hydrogen purity using its membrane-less technology. According to interviews the founders gave to ETtech (published March 10, 2026), Newtrace is also in discussions with major electrolyser original equipment manufacturers, including Reliance and L&T.
The startup notched another validation point in 2024 when it secured a 30 MW capacity allocation in the government's SIGHT (Strategic Interventions for Green Hydrogen Transition) electrolyser manufacturing incentive program—specifically, under Tranche II's smaller-unit bucket.
The Reality Check
For all that momentum, Newtrace's financials paint a familiar startup picture: early traction, heavy burn. According to data published by Entrackr on March 10, 2026, the company booked INR 1.8 crore (approximately $215,000) in revenue for the fiscal year ending March 2025. That same period, it logged losses of INR 15.6 crore—about $1.9 million.
The company had previously raised $5.65 million in a May 2023 Seed round led by Sequoia Capital India (now rebranded as Peak XV Partners) and Aavishkaar Capital, following a $1 million Pre-Seed in June 2022 from Speciale Invest and Micelio Fund. That brings total disclosed funding to $12.95 million.
A Market Racing Against Physics and Economics
Newtrace's trajectory is unfolding against a backdrop of both ambition and anxiety in India's green hydrogen sector. The National Green Hydrogen Mission, approved in January 2023 with an initial allocation of INR 19,744 crore (approximately $2.4 billion at prevailing exchange rates), set a target of 5 million metric tons per year of production capacity by 2030.
But the math is stubborn. As of early 2026, green hydrogen still costs between $4 and $10 per kilogram, depending on local conditions and scale. Grey hydrogen—the fossil fuel-derived kind—runs closer to $2 per kilogram. That gap explains why component innovations, the kind Newtrace is chasing, matter so much. Incremental efficiency gains in electrodes, membranes, or catalysts could shave dollars off production costs, making green hydrogen competitive faster than policy mandates alone.
Yet even with those innovations, industry observers are skeptical. A senior government official acknowledged in December 2025 that India may fall short of its 2030 capacity target, a rare public admission that underscores just how steep the climb remains. It's a reminder that startups like Newtrace aren't just competing for market share—they're racing to prove that the underlying economics can work at all.
Whether selling electrodes instead of electrolysers turns out to be the smarter bet, we'll know soon enough. Twelve months is a short runway for a hardware company promising commercial deliveries. If Newtrace ships on time, it will have cleared a hurdle most deeptech startups never reach. If it doesn't, this Pre-Series A might end up looking more like bridge financing than a breakout round.
